Who
Brian M. Stuglik
Director
Company insider
Files Form 4 as: Director, Puma Biotechnology; Chief Executive Officer, Verastem.
In numbers
- Trades disclosed
- 73
- Buys
- 1
- Sells
- 36
- Bought
- $7,303
- Sold
- $454K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 6 Sep 2017
- Last trade
- 12 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 15 Jun 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $58K8,100 at $7.20 | filing |
| 12 Jun 2026filed 15 Jun 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $58K8,100 at $7.20 | filing |
| 11 Jun 2026filed 15 Jun 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | VSTM VerastemBiotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 16 Dec 2025filed 18 Dec 2025 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $5,411592 at $9.14 | filing |
| 16 Sep 2025filed 18 Sep 2025 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $5,864587 at $9.99 | filing |
| 16 Jun 2025filed 20 Jun 2025 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $3,356594 at $5.65 | filing |
| 13 Jun 2025filed 17 Jun 2025 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Sold | $27K8,100 at $3.39 | filing |
| 11 Jun 2025filed 13 Jun 2025 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | VSTM Verastemoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | VSTM VerastemBiotechnology | SEC FORM 4 Code A | —8,333 at $0.00 | filing |
| 17 Mar 2025filed 19 Mar 2025 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $4,121593 at $6.95 | filing |
| 19 Dec 2024filed 20 Dec 2024 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $1,460334 at $4.37 | filing |
| 16 Dec 2024filed 20 Dec 2024 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $2,701595 at $4.54 | filing |
| 19 Sep 2024filed 20 Sep 2024 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $937336 at $2.79 | filing |
| 16 Sep 2024filed 18 Sep 2024 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $1,680600 at $2.80 | filing |
| 20 Jun 2024filed 20 Jun 2024 | VSTM VerastemBiotechnology | SEC FORM 4 Sold | $1,075335 at $3.21 | filing |
| 18 Jun 2024filed 21 Jun 2024 | PBYI Puma BiotechnologyBiotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
News
Verastem (NASDAQ:VSTM) Stock Price Target Raised at MizuhoVSTM · tickerreport.com · 16 Oct 2026Verastem (NASDAQ:VSTM) Shares Gap Up – Time to Buy?VSTM · tickerreport.com · 14 Oct 2026Verastem (NASDAQ:VSTM) Stock Falls 7% – Here's What HappenedVSTM · themarketsdaily.com · 13 Oct 2026Head to Head Contrast: Aurinia Pharmaceuticals (NASDAQ:AUPH) & Puma Biotechnology (NASDAQ:PBYI)PBYI · dailypolitical.com · 7 Oct 2026
0 headlines in the last 90 days name Brian M. Stuglik; 4 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.